Analyst Consensus ?
ConsensusBuy26 ratings
Bullish1765.4%
Neutral934.6%
Bearish00.0%
RTX Corporation · RTX · FY2025 Q3 · Calendar Q4 2025
RTX raises 2025 outlook as Q3 sales and backlog accelerate
The quarter supports a constructive view of RTX's demand trajectory: resilient commercial aerospace activity and defense munitions demand accompanied stronger sales, a larger backlog and raised full-year guidance. The key test is whether capacity expansion and GTF execution can convert demand into sustainable margin and cash-flow improvement.
Reported Before market openNYSEIndustrials
$248.90B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.70
Consensus $1.41
EPS surprise
+20.6%
Reported versus consensus
Reported revenue
$22.48B
Consensus $21.30B
Revenue surprise
+5.5%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+7.7%
Event window
SPY move
-0.0%
Same window
Abnormal move
+7.7%
Stock minus SPY
Volume
2.6×
Versus trailing sessions
Subsequent drift
+1.0%
Up to 20 sessions
RTXSPY benchmark
Ask FN2 about RTX FY2025 Q3
Transcript, numbers and history already loaded
Why did RTX rise 7.7% after beating EPS estimates in FY2025 Q3?What changed in RTX's guidance and outlook in FY2025 Q3?Give me the bull and bear case for RTX after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the reported picture strengthened: organic sales growth accelerated from 9% to 13%, backlog increased from $236 billion to $251 billion, and management raised full-year sales and EPS guidance. The focus shifted toward executing capacity expansions and the 30% GTF MRO output target, while tariff, supply-chain and negative-engine-margin risks remained.
Guidance delta
Management raised full-year adjusted sales outlook to $86.5-$87 billion and EPS outlook to $6.10-$6.20; free-cash-flow target remained $7-$7.5 billion.
Key takeaways
- Q3 organic sales rose 13%, with double-digit growth across commercial OE, aftermarket and defense.
- Backlog reached $251 billion and book-to-bill was 1.63, indicating strong order inflow.
- GTF MRO output was on track for a 30% annual increase, while defense demand centered on GEM-T, AMRAAM and Coyote.
Management priorities
- Expand critical manufacturing capacity and Raytheon capacity.
- Scale AI-driven analytics across production, inventory and munitions lines.
- Continue debt reduction, dividend growth and planned capital spending.
Follow RTX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$183.26Current
$85Low
$174.22Average
$250High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 5, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Market Perform | Market Perform | Maintain | Sep 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 27, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 24, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 24, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 4, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 2, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 28, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 27, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 22, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2025 |
| Baird | Outperform | Neutral | Upgrade | Mar 19, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 2, 2025 |
| Alembic Global | Overweight | Neutral | Upgrade | Jul 30, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Nov 15, 2023 |
| DZ Bank | Hold | Buy | Downgrade | Sep 14, 2023 |
| Argus Research | Hold | Buy | Downgrade | Jul 31, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 26, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 12, 2023 |
| Vertical Research | Buy | Hold | Upgrade | Jul 10, 2020 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 2, 2020 |
| CFRA | Buy | Buy | Maintain | May 7, 2020 |
| Drexel Hamilton | Buy | Buy | Maintain | Mar 19, 2012 |
| Sterne Agee | Buy | Buy | Maintain | Mar 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $183.26. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Douglas Harned | $223 | $190.99 | +21.7% | Sep 23, 2026 |
| Bernstein | Douglas Harned | $232 | $215.22 | +26.6% | Aug 3, 2026 |
| Argus Research | Analyst unavailable | $245 | $211.9 | +33.7% | Jul 30, 2026 |
| Deutsche Bank | Analyst unavailable | $238 | $217.52 | +29.9% | Jul 27, 2026 |
| Jefferies | Analyst unavailable | $250 | $212.79 | +36.4% | Jul 26, 2026 |
| RBC Capital | Analyst unavailable | $250 | $213.55 | +36.4% | Jul 24, 2026 |
| Susquehanna | Charles Minervino | $245 | $213.24 | +33.7% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $240 | $209.16 | +31.0% | Jul 24, 2026 |
| Morgan Stanley | Kristine Liwag | $240 | $209.16 | +31.0% | Jul 24, 2026 |
| UBS | Gavin Parsons | $215 | $209.16 | +17.3% | Jul 24, 2026 |
| Wells Fargo | Analyst unavailable | $230 | $209.16 | +25.5% | Jul 24, 2026 |
| Jefferies | Sheila Kahyaoglu | $220 | $172.55 | +20.0% | Jun 4, 2026 |
| Deutsche Bank | Scott Deuschle | $240 | $203.77 | +31.0% | Mar 5, 2026 |
| Bernstein | Analyst unavailable | $204 | $201.38 | +11.3% | Jan 29, 2026 |
| Jefferies | Sheila Kahyaoglu | $225 | $199.46 | +22.8% | Jan 28, 2026 |
| RBC Capital | Analyst unavailable | $230 | $200.88 | +25.5% | Jan 28, 2026 |
| Robert W. Baird | Peter Arment | $225 | $201.28 | +22.8% | Jan 28, 2026 |
| UBS | Gavin Parsons | $208 | $201.28 | +13.5% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $235 | $201.28 | +28.2% | Jan 28, 2026 |
| UBS | Analyst unavailable | $225 | $201.28 | +22.8% | Jan 27, 2026 |
| Vertical Research | Robert Stallard | $227 | $201.28 | +23.9% | Jan 27, 2026 |
| Susquehanna | Charles Minervino | $230 | $198.13 | +25.5% | Jan 15, 2026 |
| Bernstein | Analyst unavailable | $189 | $188.61 | +3.1% | Jan 6, 2026 |
| UBS | Analyst unavailable | $199 | $187.25 | +8.6% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $190 | $172.35 | +3.7% | Nov 25, 2025 |
| UBS | Gavin Parsons | $202 | $173.04 | +10.2% | Oct 22, 2025 |
| Morgan Stanley | Analyst unavailable | $215 | $173.04 | +17.3% | Oct 22, 2025 |
| Robert W. Baird | Peter Arment | $203 | $178 | +10.8% | Oct 22, 2025 |
| Susquehanna | Analyst unavailable | $205 | $173.04 | +11.9% | Oct 22, 2025 |
| Goldman Sachs | Noah Poponak | $168 | $173.04 | -8.3% | Oct 22, 2025 |
| Deutsche Bank | Analyst unavailable | $195 | $169.27 | +6.4% | Oct 8, 2025 |
| Bernstein | Douglas Harned | $181 | $166.58 | -1.2% | Oct 6, 2025 |
| Bernstein | Douglas Harned | $157 | $152.61 | -14.3% | Sep 10, 2025 |
| Bernstein | Douglas Harned | $154 | $146.87 | -16.0% | Jul 11, 2025 |
| Deutsche Bank | Scott Deuschle | $140 | $116.01 | -23.6% | Jan 2, 2025 |
| RBC Capital | Ken Herbert | $140 | $117.61 | -23.6% | Dec 19, 2024 |
| Deutsche Bank | Scott Deuschle | $131 | $125.43 | -28.5% | Oct 29, 2024 |
| Barclays | David Strauss | $130 | $125.43 | -29.1% | Oct 29, 2024 |
| Jefferies | Sheila Kahyaoglu | $120 | $127.21 | -34.5% | Oct 24, 2024 |
| Morgan Stanley | Kristine Liwag | $130 | $125.53 | -29.1% | Oct 23, 2024 |
| Susquehanna | Christopher Rolland | $150 | $125.53 | -18.1% | Oct 23, 2024 |
| RBC Capital | Ken Herbert | $130 | $125.53 | -29.1% | Oct 23, 2024 |
| UBS | Gavin Parsons | $133 | $125.53 | -27.4% | Oct 23, 2024 |
| Goldman Sachs | Noah Poponak | $113 | $125.53 | -38.3% | Oct 23, 2024 |
| Bank of America Securities | Ronald Epstein | $145 | $125.53 | -20.9% | Oct 23, 2024 |
| Deutsche Bank | Scott Deuschle | $129 | $123.67 | -29.6% | Oct 3, 2024 |
| Bank of America Securities | Ronald Epstein | $140 | $117.49 | -23.6% | Jul 31, 2024 |
| US Capital Advisors | Pete Skibitski | $134 | $116.88 | -26.9% | Jul 30, 2024 |
| RBC Capital | Ken Herbert | $115 | $114.98 | -37.2% | Jul 26, 2024 |
| RBC Capital | Ken Herbert | $102 | $104.99 | -44.3% | Jul 18, 2024 |
| Barclays | David Strauss | $100 | $102.44 | -45.4% | Apr 30, 2024 |
| Wells Fargo | Matthew Akers | $119 | $101.02 | -35.1% | Apr 25, 2024 |
| RBC Capital | Ken Herbert | $96 | $100.71 | -47.6% | Apr 19, 2024 |
| Jefferies | Sheila Kahyaoglu | $105 | $100.78 | -42.7% | Apr 11, 2024 |
| Wells Fargo | Matthew Akers | $120 | $97.53 | -34.5% | Apr 1, 2024 |
| RBC Capital | Ken Herbert | $82 | $75.1 | -55.3% | Sep 12, 2023 |
| Goldman Sachs | Analyst unavailable | $105 | $98.18 | -42.7% | Jan 13, 2023 |
| Credit Suisse | Analyst unavailable | $103 | $99.87 | -43.8% | Jan 12, 2023 |
| J.P. Morgan | Analyst unavailable | $107 | $98.78 | -41.6% | Dec 12, 2022 |
| Citigroup | Analyst unavailable | $104 | $99.63 | -43.3% | Dec 8, 2022 |
| Wells Fargo | Analyst unavailable | $98 | $90.27 | -46.5% | Jul 27, 2022 |
| Argus Research | John Eade | $112 | $94.91 | -38.9% | May 1, 2022 |
| Wells Fargo | Analyst unavailable | $106 | $99.19 | -42.2% | Apr 27, 2022 |
| RBC Capital | Ken Herbert | $125 | $102.11 | -31.8% | Apr 11, 2022 |
| Barclays | David Strauss | $107 | $97.04 | -41.6% | Mar 14, 2022 |
| Wolfe Research | Michael Maugeri | $111 | $94.36 | -39.4% | Feb 17, 2022 |
| Robert W. Baird | Peter Arment | $106 | $88.98 | -42.2% | Jan 26, 2022 |
| Credit Suisse | Robert Spingarn | $101 | $86.7 | -44.9% | Jul 27, 2021 |
| Cowen & Co. | Cai von Rumohr | $105 | $86.7 | -42.7% | Jul 27, 2021 |
| Langenberg & Co. | Brian Langenberg | $100 | $82.2 | -45.4% | May 3, 2021 |
| UBS | Myles Walton | $96 | $81.16 | -47.6% | Apr 28, 2021 |
| Capital One Financial | Jonathan Raviv | $85 | $81.16 | -53.6% | Apr 28, 2021 |
Track every rating change on RTX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRTX Corporation, a major player in the aerospace and defense sectors, provides sophisticated systems and extensive services to a diverse global clientele. This includes commercial entities, military organizations, and government agencies, both within the United States and internationally. The company's operations are divided into three primary business units: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace segment delivers a broad range of aerospace and defense products, alongside comprehensive aftermarket support solutions. Its customer base spans manufacturers of civil and military aircraft, commercial airlines, and operators in regional, business, general aviation, defense, and commercial space ventures. This division's offerings cover the design, production, and maintenance of aircraft interior components, such as oxygen systems, food and beverage preparation and storage facilities, galley systems, and lavatory and wastewater management.…
Historical context
All RTX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the RTX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-05T12:40:40.614731+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-05T12:40:40.611994+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-05. For educational purposes only; not investment advice.